1-7 of 7
Ingrid Glimelius
Close
Sort by
Journal Articles

CD163+ macrophages in mantle cell lymphoma induce activation of pro-survival pathways and immune suppression

Joana Matos Rodrigues, Lavanya Lokhande, Lina Maj Olsson, May Mostafa Hassan, Angelica Johansson, Anna Janská, Darshan Kumar, Lina Schmidt, Anna Nikkarinen, Peter Hollander, Ingrid Glimelius, Anna Porwit, Anna Sandström Gerdtsson, Mats Jerkeman, Sara Ek
Journal: Blood Advances
Blood Adv bloodadvances.2023012039.
https://doi.org/10.1182/bloodadvances.2023012039
Published: 2024
Includes: Supplemental data
Journal Articles

MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial

Clinical Trials & Observations
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppä, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2024) 8 (2): 407–415.
https://doi.org/10.1182/bloodadvances.2023011920
Published: 2024
Includes: Supplemental data
Journal Articles

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma

Anna Nikkarinen, Lavanya Lokhande, Rose-Marie Amini, Mats Jerkeman, Anna Porwit, Daniel Molin, Gunilla Enblad, Arne Kolstad, Riikka Räty, Martin Hutchings, Caroline E. Weibull, Peter Hollander, Sara Ek, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5304–5313.
https://doi.org/10.1182/bloodadvances.2023010052
Published: 2023
Includes: Supplemental data
Journal Articles

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation

Clinical Trials & Observations
Sara Ekberg, Karin E. Smedby, Alexandra Albertsson-Lindblad, Mats Jerkeman, Caroline E. Weibull, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2023) 7 (5): 866–874.
https://doi.org/10.1182/bloodadvances.2022007241
Published: 2023
Includes: Supplemental data
Journal Articles

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Alex Reza Gholiha, Peter Hollander, Ingrid Glimelius, Gustaf Hedstrom, Daniel Molin, Henrik Hjalgrim, Karin E. Smedby, Jamileh Hashemi, Rose-Marie Amini, Gunilla Enblad
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1671–1681.
https://doi.org/10.1182/bloodadvances.2020003664
Published: 2021
Includes: Supplemental data
Journal Articles

Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival

Clinical Trials & Observations
Ingrid Glimelius, Karin E. Smedby, Alexandra Albertsson-Lindblad, Michael J. Crowther, Sandra Eloranta, Mats Jerkeman, Caroline E. Weibull
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1638–1647.
https://doi.org/10.1182/bloodadvances.2020003645
Published: 2021
Includes: Supplemental data
Journal Articles

High proportions of PD-1 + and PD-L1 + leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Clinical Trials & Observations
Peter Hollander, Peter Kamper, Karin Ekstrom Smedby, Gunilla Enblad, Maja Ludvigsen, Julie Mortensen, Rose-Marie Amini, Stephen Hamilton-Dutoit, Francesco d’Amore, Daniel Molin, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1427–1439.
https://doi.org/10.1182/bloodadvances.2017006346
Published: 2017
Includes: Supplemental data